Biostar Pharmaceuticals
(OTC) BSPM
Biostar Pharmaceuticals Financials at a Glance
Market Cap
$300.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$317.79K
Net Income (TTM)
$935.00K
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
2927.46 (High)
Dividend
$0.00
Beta (Volatility)
2927.46 (High)
Price
$0.00
Volume
1,980
Open
$0.00
Price
$0.00
Volume
1,980
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.05
Estimated Earnings Date
N/A
Dividend
$0.00
Beta (Volatility)
2927.46 (High)
Price
$0.00
Volume
1,980
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.05
Estimated Earnings Date
N/A
BSPM News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Biostar Pharmaceuticals
BSPM Financials
Key Financial Metrics (TTM)
Gross Margin
38.39%
Operating Margin
-149.50%
Net Income Margin
-239.01%
Return on Equity
-14.04%
Return on Capital
-9.09%
Return on Assets
-13.41%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$300.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
2.64M
Volume
1.98K
Avg. Volume
92.403
Financials (TTM)
Gross Profit
-$36.75K
Operating Income
$2.79M
EBITDA
$4.90M
Operating Cash Flow
$8.59M
Capital Expenditure
$0.00
Free Cash Flow
$8.59M
Cash & ST Invst.
$364.97K
Total Debt
$2.43M
Biostar Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
$300.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$1.50
N/A
Employees
200
N/A
Net Income
-$125.00K
+92.0%
EBITDA
$222.27K
+121.0%
Quarterly Fundamentals
Total Cash
$364.97K
-44.6%
Total Debt
$2.43M
+0.2%
Accounts Receivable
$461.03K
-92.4%
Inventory
$170.56K
-61.2%
Long Term Debt
$0.00
N/A
Short Term Debt
$2.43M
+0.2%
Return on Assets
-13.41%
N/A
Return on Invested Capital
-9.66%
N/A
Free Cash Flow
-$1.41K
-100.3%
Operating Cash Flow
-$1.41K
-100.3%